{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:38Z","timestamp":1790342018047,"version":"4.1.0"},"reference-count":205,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BK21 FOUR","award":["NRF-2018R1A5A2023127"],"award-info":[{"award-number":["NRF-2018R1A5A2023127"]}]},{"name":"BK21 FOUR","award":["NRF-2020R1A2C3004973"],"award-info":[{"award-number":["NRF-2020R1A2C3004973"]}]},{"name":"BK21 FOUR","award":["NRF-2020M3E5E2038356"],"award-info":[{"award-number":["NRF-2020M3E5E2038356"]}]},{"DOI":"10.13039\/501100003725","name":"Basic Science Research","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2023127"],"award-info":[{"award-number":["NRF-2018R1A5A2023127"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Basic Science Research","doi-asserted-by":"publisher","award":["NRF-2020R1A2C3004973"],"award-info":[{"award-number":["NRF-2020R1A2C3004973"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Basic Science Research","doi-asserted-by":"publisher","award":["NRF-2020M3E5E2038356"],"award-info":[{"award-number":["NRF-2020M3E5E2038356"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ethacrynic acid (ECA) is a diuretic that inhibits Na-K-2Cl cotransporter (NKCC2) present in the thick ascending loop of Henle and muculo dens and is clinically used for the treatment of edema caused by excessive body fluid. However, its clinical use is limited due to its low bioavailability and side effects, such as liver damage and hearing loss at high doses. Despite this, ECA has recently emerged as a potential anticancer agent through the approach of drug repositioning, with a novel mechanism of action. ECA has been shown to regulate cancer hallmark processes such as proliferation, apoptosis, migration and invasion, angiogenesis, inflammation, energy metabolism, and the increase of inhibitory growth factors through various mechanisms. Additionally, ECA has been used as a scaffold for synthesizing a new material, and various derivatives have been synthesized. This review explores the potential of ECA and its derivatives as anticancer agents, both alone and in combination with adjuvants, by examining their effects on ten hallmarks of cancer and neuronal contribution to cancer. Furthermore, we investigated the trend of synthesis research of a series of ECA derivatives to improve the bioavailability of ECA. This review highlights the importance of ECA research and its potential to provide a cost-effective alternative to new drug discovery and development for cancer treatment.<\/jats:p>","DOI":"10.3390\/ijms24076712","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:30:15Z","timestamp":1680575415000},"page":"6712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent"],"prefix":"10.3390","volume":"24","author":[{"given":"Lu","family":"Yu","sequence":"first","affiliation":[{"name":"College of Pharmacy, Dongguk University, Seoul 04620, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5573-742X","authenticated-orcid":false,"given":"Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy National Cancer Center, Goyang 10408, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Bae","family":"Rho","sequence":"additional","affiliation":[{"name":"Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy National Cancer Center, Goyang 10408, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kyung","family":"Park","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dongguk University, Seoul 04620, Republic of Korea"},{"name":"Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy National Cancer Center, Goyang 10408, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-0793","authenticated-orcid":false,"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dongguk University, Seoul 04620, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjc.6601509","article-title":"Modifiable risk factors for cancer","volume":"90","author":"Stein","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4062\/biomolther.2019.135","article-title":"Tumour regression via integrative regulation of neurological, inflammatory, and hypoxic tumour microenvironment","volume":"28","author":"Lee","year":"2020","journal-title":"Biomol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","article-title":"Cancer incidence and mortality in China, 2014","volume":"30","author":"Chen","year":"2018","journal-title":"Chin. J. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: A population-based cost analysis","volume":"14","author":"Leal","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-11-0650","article-title":"Economic burden of cancer in the United States: Estimates, projections, and future research","volume":"20","author":"Yabroff","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/anie.202012687","article-title":"An ethacrynic acid-brominated BODIPY photosensitizer (EA-BPS) construct enhances the lethality of reactive oxygen species in hypoxic tumor-targeted photodynamic therapy","volume":"60","author":"Won","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1007\/s11033-022-07560-5","article-title":"Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells","volume":"49","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114339","DOI":"10.1016\/j.bcp.2020.114339","article-title":"Ethacrynic acid, a loop diuretic, suppresses epithelial-mesenchymal transition of A549 lung cancer cells via blocking of NDP-induced WNT signaling","volume":"183","author":"Yu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_13","first-page":"1","article-title":"Renotropic characteristics of ethacrynic acid: A phenoxyacetic saluretic-diuretic agent","volume":"147","author":"Beyer","year":"1965","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI104905","article-title":"Effects of ethacrynic acid (a new saluretic agent) on renal diluting and concentrating mechanisms: Evidence for site of action in the loop of Henle","volume":"43","author":"Goldberg","year":"1964","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MJT.0b013e318195e460","article-title":"The clinical pharmacology of ethacrynic acid","volume":"16","author":"Molnar","year":"2009","journal-title":"Am. J. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.0954-6820.1964.tb00636.x","article-title":"Clinical Experiences with Ethacrynic Acid, a New Non-Thiazide Saluretic Agent (MK-595)","volume":"175","author":"Sannerstedt","year":"1964","journal-title":"Acta Med. Scand."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1158\/0008-5472.CAN-07-0151","article-title":"Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide\u2013mediated pathway independent of glutathione S-transferase P1-1 inhibition","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res."},{"key":"ref_18","first-page":"1186","article-title":"Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer","volume":"270","author":"Lacreta","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0008-6363(96)00134-4","article-title":"Vascular effects of loop diuretics","volume":"32","author":"Dormans","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/MJT.0b013e3181961264","article-title":"The pleiotropic effects of ethacrynic acid","volume":"16","author":"Somberg","year":"2009","journal-title":"Am. J. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.3.5558.152","article-title":"Hepatocellular damage with ethacrynic acid","volume":"3","author":"Datey","year":"1967","journal-title":"Br. Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joto.2016.10.001","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J. Otol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archotol.1972.00770080684011","article-title":"Ototoxicity of the ethacrynic acid","volume":"95","author":"Prazma","year":"1972","journal-title":"Arch. Otolaryngol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.heares.2009.08.008","article-title":"Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid","volume":"259","author":"Ding","year":"2010","journal-title":"Hear. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.heares.2006.07.015","article-title":"Cell death after co-administration of cisplatin and ethacrynic acid","volume":"226","author":"Ding","year":"2007","journal-title":"Hear. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15436\/2381-1404.18.1666","article-title":"Ethacrynic Acid and Ciclopiroxolamine in Various Cancer Cells","volume":"4","author":"Emekwue","year":"2018","journal-title":"Int. J. Hematol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0006-2952(90)90273-N","article-title":"Antiproliferative effects of glutathione S-transferase inhibitors on the K562 cell line","volume":"39","author":"Yutaka","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"58038","DOI":"10.18632\/oncotarget.10846","article-title":"Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_31","first-page":"5375","article-title":"Effect of Wnt inhibitors in pancreatic cancer","volume":"34","author":"Wall","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113920","DOI":"10.1016\/j.bcp.2020.113920","article-title":"Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells","volume":"175","author":"Lee","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/febs.14813","article-title":"Glutathione S-transferase omega 1 inhibition activates JNK-mediated apoptotic response in breast cancer stem cells","volume":"286","author":"Manupati","year":"2019","journal-title":"FEBS J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0360-3016(95)02040-3","article-title":"Ethacrynic acid: A novel radiation enhancer in human carcinoma cells","volume":"34","author":"Khil","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/iju.IJU_296_17","article-title":"New therapies in nonmuscle invasive bladder cancer treatment","volume":"34","author":"Rayn","year":"2018","journal-title":"Indian J. Urol."},{"key":"ref_36","first-page":"325","article-title":"Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid","volume":"25","author":"Schmidt","year":"2011","journal-title":"In Vivo"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1349-7006.2003.tb01371.x","article-title":"Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine","volume":"94","author":"Aizawa","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5662080","article-title":"Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR\/T790M-Mutated NSCLC by Inhibiting WNT\/Beta-Catenin Pathway Activation","volume":"2021","author":"Zhang","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lu, D., Liu, J.X., Endo, T., Zhou, H., Yao, S., Willert, K., Schmidt-Wolf, I.G., Kipps, T.J., and Carson, D.A. (2009). Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt\/\u03b2-catenin pathway. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008294"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1021\/acs.molpharmaceut.8b00250","article-title":"Chemoproteomic profiling reveals ethacrynic acid targets adenine nucleotide translocases to impair mitochondrial function","volume":"15","author":"Ye","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"61124","DOI":"10.1039\/C4RA12040J","article-title":"Nanoparticle mediated delivery of a GST inhibitor ethacrynic acid for sensitizing platinum based chemotherapy","volume":"4","author":"Yang","year":"2014","journal-title":"RSC Adv."},{"key":"ref_42","first-page":"6854","article-title":"Utilizing ethacrynic acid and ciclopirox olamine in liver cancer","volume":"16","author":"Weiher","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_43","first-page":"4719","article-title":"Targeting the Wnt\/beta-catenin pathway in multiple myeloma","volume":"33","author":"Schmeel","year":"2013","journal-title":"Anticancer. Res."},{"key":"ref_44","first-page":"4101","article-title":"Targeting the Wnt\/beta-catenin pathway in renal cell carcinoma","volume":"34","author":"Schmeel","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.leukres.2012.01.025","article-title":"In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma","volume":"36","author":"Kim","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"lb637","DOI":"10.1096\/fasebj.27.1_supplement.lb637","article-title":"Effects of alpha, beta-unsaturated cinnamyl-like aromatic compounds on the viability of a model human cancer (MCF-7) cell line","volume":"27","author":"Muhammad","year":"2013","journal-title":"FASEB J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.apsb.2021.10.013","article-title":"\u201cPincer movement\u201d: Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles","volume":"12","author":"Niu","year":"2022","journal-title":"Acta Pharmaceutica Sin. B."},{"key":"ref_48","unstructured":"Huang, L., Xie, L., Qiu, Y., Hu, P., and Ye, X. (2017). Ethacrynic acid promotes apoptosis in lung cancer A549 cells when combined with cisplatin chemotherapy. J. Third Mil. Med. Univ., 1720\u20131727."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1349-7006.2000.tb00900.x","article-title":"Induction of apoptosis and cell cycle arrest in mouse colon 26 cells by benastatin A","volume":"91","author":"Kakizaki","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-12-0770","article-title":"Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide\u2013Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1Apoptosis Induction by Arsenic Trioxide plus Ethacrynic Acid","volume":"18","author":"Wang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(99)00107-X","article-title":"Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells","volume":"264","author":"Seyfried","year":"1999","journal-title":"Neurosci. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00357-X","article-title":"Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid","volume":"207","author":"Rizzardini","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mrfmmm.2011.07.006","article-title":"Is telomerase a viable target in cancer?","volume":"730","author":"Buseman","year":"2012","journal-title":"Mutat. Res.\/Fundam. Mol. Mech. Mutagen."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1101\/gad.12.12.1769","article-title":"Myc activates telomerase","volume":"12","author":"Wang","year":"1998","journal-title":"Genes Dev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/0008-5472.CAN-03-2907","article-title":"Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2017.00001","article-title":"Transcriptional regulation of telomerase reverse transcriptase (TERT) by MYC","volume":"5","author":"Khattar","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/abbi.2002.2762","article-title":"Calcium-mediated telomerase activity in ovarian epithelial cells","volume":"399","author":"Kruk","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1389450114666140106101412","article-title":"Targeting tumor suppressor p53 for cancer therapy: Strategies, challenges and opportunities","volume":"15","author":"Hong","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2741\/Somasund","article-title":"Tumor suppressor p53: Regulation and function","volume":"5","author":"Somasundaram","year":"2000","journal-title":"Front. Biosci. Landmark"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2015.03.016","article-title":"Genotoxic effect of ethacrynic acid and impact of antioxidants","volume":"286","author":"Ward","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1158\/1538-7445.AM2011-218","article-title":"GSTP1 expression in human cancers decreases p53 protein levels and markedly attenuates p53-dependent responses to therapy-induced DNA damage","volume":"71","author":"Yusuf","year":"2011","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10555-013-9429-5","article-title":"The detection and implication of genome instability in cancer","volume":"32","author":"Pikor","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1158\/1538-7445.AM2017-2570","article-title":"Induction of mild oxidative stress as a strategy for reactivation of mutant p53 proteins: KSS72, a small molecule derived from ethacrynic acid restores the biological functions of R248W\/Q mutant","volume":"77","author":"Punganuru","year":"2017","journal-title":"Cancer Res."},{"key":"ref_65","first-page":"65","article-title":"Cellular energetics as a target for tumor cell elimination","volume":"81","author":"Maximchik","year":"2016","journal-title":"Biochemistry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"62726","DOI":"10.18632\/oncotarget.10911","article-title":"Oncogenic regulation of tumor metabolic reprogramming","volume":"7","author":"Cascante","year":"2016","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Schiliro, C., and Firestein, B.L. (2021). Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells, 10.","DOI":"10.3390\/cells10051056"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1085\/jgp.54.5.650","article-title":"The relationship between cell membrane potassium ion transport and glycolysis: The effect of ethacrynic acid","volume":"54","author":"Gordon","year":"1969","journal-title":"J. Gen. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/lary.1978.88.1.12","article-title":"Effect of ethacrynic acid, furosemide, and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascularis","volume":"88","author":"Kusakari","year":"1978","journal-title":"Laryngoscope"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2307\/3283195","article-title":"Presence and cellular distribution of a 60-kDa protein related to mitochondrial hsp60 in Giardia lamblia","volume":"80","author":"Soltys","year":"1994","journal-title":"J. Parasitol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0006-2952(68)90060-9","article-title":"Site of ethacrynic acid action on Ehrlich ascites tumor cells","volume":"17","author":"Gordon","year":"1968","journal-title":"Biochem. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(95)01376-8","article-title":"Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis","volume":"711","author":"Huang","year":"1996","journal-title":"Brain Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Rogers","year":"2019","journal-title":"Cancer Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4062\/biomolther.2013.066","article-title":"Ethacrynic acid inhibits sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization via transglutaminase-2 inhibition","volume":"21","author":"Byun","year":"2013","journal-title":"Biomol. Ther."},{"key":"ref_76","first-page":"1","article-title":"Glutathione S-transferase \u03c9 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non-small cell lung cancer cells, via the JAK\/STAT3 signaling pathway","volume":"23","author":"Wang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bmcl.2010.12.074","article-title":"Inhibitory effects of ethacrynic acid analogues lacking the \u03b1, \u03b2-unsaturated carbonyl unit and para-acylated phenols on human cancer cells","volume":"21","author":"Bryant","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.bmcl.2010.01.144","article-title":"Ethacrynic acid analogues lacking the \u03b1, \u03b2-unsaturated carbonyl unit\u2014Potential anti-metastatic drugs","volume":"20","author":"Janser","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: A key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jcb.24438","article-title":"HIFs, angiogenesis, and cancer","volume":"114","author":"Yang","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2013.04.044","article-title":"Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1\u03b1 interaction with p300","volume":"434","author":"Na","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/0008-5472.CAN-07-1183","article-title":"Nerve growth factor is a potential therapeutic target in breast cancer","volume":"68","author":"Adriaenssens","year":"2008","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-4598-9-157","article-title":"Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways","volume":"9","author":"Romon","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1634\/theoncologist.2015-0282","article-title":"How cancers escape immune destruction and mechanisms of action for the new significantly active immune therapies: Helping nonimmunologists decipher recent advances","volume":"21","author":"Messerschmidt","year":"2016","journal-title":"Oncologist"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"Volume 35","author":"Vinay","year":"2015","journal-title":"Seminars in Cancer Biology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","article-title":"Immunosuppressive cells in cancer: Mechanisms and potential therapeutic targets","volume":"15","author":"Tie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.shk.0000150629.53699.3f","article-title":"Ethacrynic acid inhibits multiple steps in the NF-\u03baB signaling pathway","volume":"23","author":"Han","year":"2005","journal-title":"Shock"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1165\/rcmb.2013-0544OC","article-title":"The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-\u03baB\u2013mediated release of high-mobility group box-1","volume":"52","author":"Wang","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"40520","DOI":"10.1074\/jbc.M111.292961","article-title":"The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor \u03b2 (TGF-\u03b2) signaling and the development of regulatory T cells","volume":"286","author":"Zhao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"21631","DOI":"10.18632\/oncotarget.7795","article-title":"High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/jpet.105.092841","article-title":"The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells","volume":"316","author":"Killeen","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.6061\/clinics\/2018\/e332","article-title":"Ethacrynic acid decreases expression of proinflammatory intestinal wall cytokines and ameliorates gastrointestinal stasis in murine postoperative ileus","volume":"73","author":"Harada","year":"2018","journal-title":"Clinics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41420-021-00450-y","article-title":"Role of the nervous system in cancers: A review","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.21037\/atm.2018.01.01","article-title":"Tumor progression: The neuronal input","volume":"6","author":"Arese","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1470-2045(04)01431-7","article-title":"Tumour-cell migration, invasion, and metastasis: Navigation by neurotransmitters","volume":"5","author":"Entschladen","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"17416","DOI":"10.1016\/S0021-9258(18)71510-X","article-title":"An ATP-driven Cl\u2212 pump in the brain","volume":"264","author":"Shiroya","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1073\/pnas.86.8.2863","article-title":"The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes","volume":"86","author":"Inoue","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(90)90423-4","article-title":"Ethacrynic acid-induced convulsions and brain noradrenaline in mice","volume":"179","author":"Inoue","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0006-8993(91)91060-E","article-title":"Ethacrynic acid-induced glutamate release from mouse brain synaptosomes","volume":"543","author":"Inoue","year":"1991","journal-title":"Brain Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-8993(99)01554-1","article-title":"Long-lasting c-fos and NGF mRNA expressions and loss of perikaryal parvalbumin immunoreactivity in the development of epileptogenesis after ethacrynic acid-induced seizure","volume":"834","author":"Suzukawa","year":"1999","journal-title":"Brain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/00001756-199412000-00007","article-title":"Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF","volume":"5","author":"Knipper","year":"1994","journal-title":"Neuroreport"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1002\/jcp.29317","article-title":"C-Fos separation from Lamin A\/C by GDF15 promotes colon cancer invasion and metastasis in inflammatory microenvironment","volume":"235","author":"Ding","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1158\/1078-0432.CCR-16-2811","article-title":"Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinomac-Fos in the Enhancement of Cancer Stem-like Properties","volume":"23","author":"Muhammad","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng859","article-title":"C-fos regulates neuronal excitability and survival","volume":"30","author":"Zhang","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10555-006-9017-z","article-title":"Voltage-sensitive ion channels and cancer","volume":"25","author":"Fiske","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"20130108","DOI":"10.1098\/rstb.2013.0108","article-title":"Ion channels in cancer: Future perspectives and clinical potential","volume":"369","author":"Lang","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00232-005-0782-3","article-title":"Clinical relevance of ion channels for diagnosis and therapy of cancer","volume":"205","year":"2005","journal-title":"J. Membr. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2170\/physiolsci.RP010806","article-title":"Furosemide, a blocker of Na+\/K+\/2Cl\u2212 cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0\/G1 state","volume":"56","author":"Shiozaki","year":"2006","journal-title":"J. Physiol. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0002-9440(10)64792-X","article-title":"The mRNA of L-type calcium channel elevated in colon cancer: Protein distribution in normal and cancerous colon","volume":"157","author":"Wang","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1097-4652(200001)182:1<109::AID-JCP12>3.0.CO;2-A","article-title":"Overexpression of the Na+\/K+\/Cl\u2212 cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts","volume":"182","author":"Panet","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"732922","DOI":"10.3389\/fphar.2021.732922","article-title":"Loop Diuretics Inhibit Ischemia-Induced Intracellular Ca2+ Overload in Neurons via the Inhibition of Voltage-Gated Ca2+ and Na+ Channels","volume":"12","author":"Katnik","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_116","first-page":"863","article-title":"Ethacrynic acid inhibits airway smooth muscle contraction in mice","volume":"71","author":"Zhao","year":"2019","journal-title":"Sheng Li Xue Bao"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng0404-320","article-title":"Shutting down Wnt signal\u2013activated cancer","volume":"36","author":"Taketo","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-14-0184","article-title":"\u03b2-catenin contributes to lung tumor development induced by EGFR mutations","volume":"74","author":"Nakayama","year":"2014","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-419X(03)00005-2","article-title":"Caught up in a Wnt storm: Wnt signaling in cancer","volume":"1653","author":"Giles","year":"2003","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","article-title":"A second canon: Functions and mechanisms of \u03b2-catenin-independent Wnt signaling","volume":"5","author":"Veeman","year":"2003","journal-title":"Dev. Cell"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ahmed, K., Shaw, H.V., Koval, A., and Katanaev, V.L. (2016). A second WNT for old drugs: Drug repositioning against WNT-dependent cancers. Cancers, 8.","DOI":"10.3390\/cancers8070066"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e06554","DOI":"10.7554\/eLife.06554","article-title":"Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5\/6, and proteoglycan","volume":"4","author":"Chang","year":"2015","journal-title":"Elife"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1101\/gad.228544.113","article-title":"Structure and function of Norrin in assembly and activation of a Frizzled 4\u2013Lrp5\/6 complex","volume":"27","author":"Ke","year":"2013","journal-title":"Genes Dev."},{"key":"ref_125","first-page":"1389","article-title":"Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment","volume":"7","author":"Santiago","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-021-00323-7","article-title":"The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomarker Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1111\/bph.13963","article-title":"Inhibition of nuclear Wnt signalling: Challenges of an elusive target for cancer therapy","volume":"174","author":"Lyou","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41389-017-0025-3","article-title":"Glutathione transferases: Substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases","volume":"7","author":"Allocati","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4613-1601-5_11","article-title":"Glutathione S\u2014Transferase and drug resistance","volume":"48","author":"Cazenave","year":"1989","journal-title":"Drug Resist. Cancer Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.05.012","article-title":"Glutathione transferases and development of new principles to overcome drug resistance","volume":"500","author":"Sau","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Townsend","year":"2003","journal-title":"Oncogene"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/acs.organomet.6b00197","article-title":"Arene osmium complexes with ethacrynic acid-modified ligands: Synthesis, characterization, and evaluation of intracellular glutathione S-transferase inhibition and antiproliferative activity","volume":"35","author":"Agonigi","year":"2016","journal-title":"Organometallics"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/187152009789056895","article-title":"Glutathione transferases as targets for cancer therapy","volume":"9","author":"Ruzza","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2013.06.003","article-title":"FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1","volume":"205","author":"Musdal","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"ref_135","first-page":"6059","article-title":"Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid","volume":"51","author":"LaCreta","year":"1991","journal-title":"Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0006-2952(94)00474-Z","article-title":"Inhibition of glutathione-related enzymes and cytotoxicity of ethacrynic acid and cyclosporine","volume":"49","author":"Hoffman","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0006-2952(95)00263-Y","article-title":"Influence of ethacrynic acid on glutathione S-transferase \u03c0 transcript and protein half-lives in human colon cancer cells","volume":"50","author":"Shen","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fonc.2011.00039","article-title":"Glutathione S-transferases in pediatric cancer","volume":"1","author":"Luo","year":"2011","journal-title":"Front. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0076-6879(05)01019-0","article-title":"Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets","volume":"401","author":"Townsend","year":"2005","journal-title":"Methods Enzymol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(98)00307-3","article-title":"Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid","volume":"136","author":"Caffrey","year":"1999","journal-title":"Cancer Lett."},{"key":"ref_141","first-page":"2621","article-title":"Denitrosation of 1, 3-bis (2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells","volume":"49","author":"Smith","year":"1989","journal-title":"Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bjc.1992.145","article-title":"A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines","volume":"65","author":"Rhodes","year":"1992","journal-title":"Br. J. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"84559","DOI":"10.18632\/oncotarget.19187","article-title":"Novel strategies to prevent the development of multidrug resistance (MDR) in cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_144","first-page":"915","article-title":"Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1","volume":"54","author":"Ploemen","year":"1994","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0014-5793(96)00718-1","article-title":"Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP","volume":"391","author":"Zaman","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-5793(98)01546-4","article-title":"GSTP1-1 stereospecifically catalyzes glutathione conjugation of ethacrynic acid","volume":"441","author":"Rietjens","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0167-4838(93)90245-M","article-title":"Interactions of glutathione S-transferase-\u03c0 with ethacrynic acid and its glutathione conjugate","volume":"1164","author":"Awasthi","year":"1993","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/0006-2952(90)90465-W","article-title":"Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate","volume":"40","author":"Ploemen","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/bi962316i","article-title":"The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione conjugate","volume":"36","author":"Oakley","year":"1997","journal-title":"Biochemistry"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0969-2126(01)00206-4","article-title":"Structural analysis of human alpha-class glutathione transferase A1-1 in the apo-form and in complexes with ethacrynic acid and its glutathione conjugate","volume":"3","author":"Cameron","year":"1995","journal-title":"Structure"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"8631","DOI":"10.7314\/APJCP.2014.15.20.8631","article-title":"Expression and function of GSTA1 in lung cancer cells","volume":"15","author":"Pan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3892\/etm.2017.4663","article-title":"Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.abb.2006.04.006","article-title":"Glutathione S-transferases as antioxidant enzymes: Small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis","volume":"452","author":"Sharma","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_154","first-page":"457","article-title":"Human Glutathione S-Transferase A1-1 binding with naturally occurring ligands: Assessment by docking simulations","volume":"1","author":"Srivastava","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.18632\/oncotarget.27558","article-title":"Quinacrine inhibits GSTA1 activity and induces apoptosis through G1\/S arrest and generation of ROS in human non-small cell lung cancer cell lines","volume":"11","author":"Kumar","year":"2020","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1007\/s13277-014-2394-y","article-title":"Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/pr060402r","article-title":"Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines","volume":"6","author":"Yan","year":"2007","journal-title":"J. Proteome Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/carcin\/bgq031","article-title":"Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity","volume":"31","author":"Piaggi","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0006-2952(94)90420-0","article-title":"Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells","volume":"47","author":"Chen","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"ref_160","first-page":"319","article-title":"Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance","volume":"70","author":"Drozd","year":"2016","journal-title":"Adv. Hyg. Exp. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"29542","DOI":"10.1074\/jbc.M602500200","article-title":"SLCO\/OATP-like transport of glutathione in FasL-induced apoptosis: Glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis","volume":"281","author":"Franco","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/celldisc.2016.31","article-title":"Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer","volume":"2","author":"Li","year":"2016","journal-title":"Cell Discov."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14728222.5.4.477","article-title":"Glutathione S-transferases as emerging therapeutic targets","volume":"5","author":"Tew","year":"2001","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02897285","article-title":"Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues","volume":"26","author":"Nagourney","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_165","first-page":"480","article-title":"The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance","volume":"294","author":"Kruh","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_166","first-page":"357","article-title":"Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs","volume":"54","author":"Grant","year":"1994","journal-title":"Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.1996.0706","article-title":"Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells","volume":"222","author":"Ciaccio","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.freeradbiomed.2008.08.018","article-title":"Induction of adaptive response and enhancement of PC12 cell tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation","volume":"45","author":"Omata","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kB in development and progression of human cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"53725","DOI":"10.1074\/jbc.M407627200","article-title":"Transglutaminase 2 induces nuclear factor-\u03baB activation via a novel pathway in BV-2 microglia","volume":"279","author":"Lee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Park, M.K., and Lee, C.H. (2019). Role of sphingosylphosphorylcholine in tumor and tumor microenvironment. Cancers, 11.","DOI":"10.3390\/cancers11111696"},{"key":"ref_172","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1021\/jacs.7b04880","article-title":"Discovery of a covalent kinase inhibitor from a DNA-encoded small-molecule library\u00d7 protein library selection","volume":"139","author":"Chan","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Tamagnone, L., Zacchigna, S., and Rehman, M. (2018). Taming the Notch transcriptional regulator for cancer therapy. Molecules, 23.","DOI":"10.3390\/molecules23020431"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2406","article-title":"Key signalling nodes in mammary gland development and cancer: Myc","volume":"11","author":"Hynes","year":"2009","journal-title":"Breast Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cmdc.201800105","article-title":"Development of an efficient dual-action GST-inhibiting anticancer platinum (IV) prodrug","volume":"13","author":"Lee","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1958174","DOI":"10.1155\/2016\/1958174","article-title":"The Nrf2\/HO-1 axis in cancer cell growth and chemoresistance","volume":"2016","author":"Furfaro","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2009.08.028","article-title":"Targeting NRF2 signaling for cancer chemoprevention","volume":"244","author":"Kwak","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1073\/pnas.1002890107","article-title":"Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Caminade, A.-M. (2020). Phosphorus dendrimers as nanotools against cancers. Molecules, 25.","DOI":"10.3390\/molecules25153333"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejmech.2016.05.063","article-title":"A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action","volume":"122","author":"Mignani","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4172\/2161-0444.1000511","article-title":"Encouraging Effects of Ethacrynic Acid Derivatives Possessing a Privileged \u03b1, \u03b2-Unsaturated Carbonyl Structure Scaffold","volume":"8","author":"Dong","year":"2018","journal-title":"Med. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/molecules14010019","article-title":"Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid","volume":"14","author":"Dude","year":"2008","journal-title":"Molecules"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopha.2012.10.011","article-title":"6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest","volume":"67","author":"Zhang","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1039\/C4NR05983B","article-title":"Investigations on dendrimer space reveal solid and liquid tumor growth-inhibition by original phosphorus-based dendrimers and the corresponding monomers and dendrons with ethacrynic acid motifs","volume":"7","author":"Mignani","year":"2015","journal-title":"Nanoscale"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"El Abbouchi, A., El Brahmi, N., Hiebel, M.-A., Ghammaz, H., El Fahime, E., Bignon, J., Guillaumet, G., Suzenet, F., and El Kazzouli, S. (2023). Improvement of the Chemical Reactivity of Michael Acceptor of Ethacrynic Acid Correlates with Antiproliferative Activities. Molecules, 28.","DOI":"10.3390\/molecules28020910"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1248\/cpb.57.714","article-title":"Combining a solution-phase derived library with in-situ cellular bioassay: Prompt screening of amide-forming minilibraries using MTT assay","volume":"57","author":"Chiang","year":"2009","journal-title":"Chem. Pharm. Bull."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"127426","DOI":"10.1016\/j.bmcl.2020.127426","article-title":"Synthesis and biological evaluation of ethacrynic acid derivatives bearing sulfonamides as potent anti-cancer agents","volume":"30","author":"Hiebel","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"105293","DOI":"10.1016\/j.bioorg.2021.105293","article-title":"Synthesis and evaluation of a novel class of ethacrynic acid derivatives containing triazoles as potent anticancer agents","volume":"115","author":"Hiebel","year":"2021","journal-title":"Bioorganic Chem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.bmc.2012.02.011","article-title":"The synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitors","volume":"20","author":"Li","year":"2012","journal-title":"Bioorganic Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1158\/1535-7163.MCT-12-1224","article-title":"Ethacrynic Acid Oxadiazole Analogs Induce Apoptosis in Malignant Hematologic Cells through Downregulation of Mcl-1 and c-FLIP, Which Was Attenuated by GSTP1-1Apoptosis Induction by Ethacrynic Acid Oxadiazole Analogs","volume":"12","author":"Liu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2016.04.062","article-title":"Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid","volume":"26","author":"Punganuru","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.bmcl.2011.01.068","article-title":"Solution-phase parallel synthesis and screening of anti-tumor activities from fenbufen and ethacrynic acid libraries","volume":"21","author":"Su","year":"2011","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/jm9011565","article-title":"Novel oxadiazole analogues derived from ethacrynic acid: Design, synthesis, and structure\u2212 activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation","volume":"53","author":"Yang","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.bmc.2005.03.046","article-title":"Synthesis and structure\u2013activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition","volume":"13","author":"Zhao","year":"2005","journal-title":"Bioorganic Med. Chem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2174\/092986706776872934","article-title":"Advance in antitumor agents targeting glutathione-S-transferase","volume":"13","author":"Zhao","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0006-2952(93)90137-L","article-title":"Isoenzyme selective irreversible inhibition of rat and human glutathione S-transferases by ethacrynic acid and two brominated derivatives","volume":"45","author":"Ploemen","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2017.08.021","article-title":"Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo","volume":"144","author":"Li","year":"2017","journal-title":"Biomaterials"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"178-1","DOI":"10.1096\/fasebj.31.1_supplement.178.1","article-title":"Synthesis of a novel non-diuretic, brain-penetrating, ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models","volume":"31","author":"Madala","year":"2017","journal-title":"FASEB J."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1002\/anie.201412276","article-title":"Identification of covalent bromodomain binders through DNA display of small molecules","volume":"54","author":"Daguer","year":"2015","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:09:37Z","timestamp":1760123377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":205,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076712"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076712","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}